Raymond James & Associates Ark Genomic Revolution ETF (De Transaction History
Raymond James & Associates
- $150 Billion
- Q2 2024
A detailed history of Raymond James & Associates transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Raymond James & Associates holds 82,411 shares of ARKG stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,411
Previous 114,515
28.03%
Holding current value
$2 Million
Previous $3.29 Million
41.24%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ARKG
# of Institutions
308Shares Held
20.9MCall Options Held
2.79MPut Options Held
6.56M-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$66.8 Million3.23% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$54.7 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$42.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$37.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$35.3 Million0.0% of portfolio